SAN DIEGO--(BUSINESS WIRE)--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the only touchscreen insulin pumps available in the
United States, plans to release its first quarter 2017 results after the
financial markets close on Thursday, April 27, 2017. The Company will
hold a conference call and simultaneous webcast on the same day at
4:30pm Eastern Time (1:30pm Pacific Time), to discuss its first quarter
2017 financial and operating results.
Conference Call/Webcast Details:
April 27, 2017
Time: 4:30pm Eastern Time (1:30pm Pacific
Toll Free Dial-In Number: (855) 427-4396
Dial-In Number: (484) 756-4261
Conference ID: 4168494
An archive of the webcast will be available for 30 days following the
event on Tandem Diabetes Care's Investor Center website located at http://investor.tandemdiabetes.com
in the "Events & Presentations" section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company with an innovative, user-centric and
integrated approach to the design, development and commercialization of
products for people with diabetes who use insulin. The Company
manufactures and sells the t:slim X2™ Insulin Pump, the slimmest and
smallest durable insulin pump currently on the market, the t:flex®
Insulin Pump, the first pump designed for people with greater insulin
requirements, and the t:slim G4™ Insulin Pump, the first continuous
glucose monitoring-enabled pump with touchscreen simplicity. Tandem is
based in San Diego, California.
Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2,
#tslimG4, #tflex, #tconnect, and $TNDM.
Follow Tandem Diabetes Care
on Facebook at www.facebook.com/TandemDiabetes.
Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.
t:slim, t:flex and Tandem Diabetes Care are registered trademarks, and
t:slim X2 and t:slim G4 are trademarks of Tandem Diabetes Care, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170413005912/en/
for Tandem Diabetes Care, Inc.
Susan Morrison, 858-366-6900 x7005
Source: Tandem Diabetes Care, Inc.
News Provided by Acquire Media